W. Zhen
University of Nebraska Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by W. Zhen.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2002
Gerry F. Funk; Lucy Hynds Karnell; Robert A. Robinson; W. Zhen; Douglas K. Trask; Henry T. Hoffman
Oral cancer has been identified as a significant public health threat. Systematic evaluation of the impact of this disease on the US population is of great importance to health care providers and policy makers.
Cancer | 2002
John H. Lee; Frank Barich; Lucy Hynds Karnell; Robert A. Robinson; W. Zhen; Bruce J. Gantz; Henry T. Hoffman
Malignant paragangliomas of the head and neck are rare, with previous reports limited to nine or fewer patients. The current review included 59 cases extracted from the National Cancer Data Base that were diagnosed between 1985–1996.
Journal of Magnetic Resonance Imaging | 2000
Nina A. Mayr; William T. C. Yuh; Jeffrey C. Arnholt; James C. Ehrhardt; Joel I. Sorosky; Vincent A. Magnotta; Kevin S. Berbaum; W. Zhen; Arnold C. Paulino; Larry W. Oberley; Anil K. Sood; John M. Buatti
The purpose of this study was to assess heterogeneity of tumor microcirculation determined by dynamic contrast‐enhanced magnetic resonance (MR) imaging and its prognostic value for tumor radiosensitivity and long‐term tumor control using pixel‐by‐pixel analysis of the dynamic contrast enhancement. Sixteen patients with advanced cervical cancer were examined with dynamic contrast‐enhanced MR imaging at the time of radiation therapy. Pixel‐by‐pixel statistical analysis of the ratio of post‐ to precontrast relative signal intensity (RSI) values in the tumor region was performed to generate pixel RSI distributions of dynamic enhancement patterns. Histogram parameters were correlated with subsequent tumor control based on long‐term cancer follow‐up (median follow‐up 4.6 years; range 3.8–5.2 years). The RSI distribution histograms showed a wide spectrum of heterogeneity in the dynamic enhancement pattern within the tumor. The quantity of low‐enhancement regions (10th percentile RSI < 2.5) significantly predicted subsequent tumor recurrence (88% vs. 0%, P = 0.0004). Discriminant analysis based on both 10th percentile RSI and pixel number (reflective of tumor size) further improved the prediction rate (100% correct prediction of subsequent tumor control vs. recurrence). These preliminary results suggest that quantification of the extent of poor vascularity regions within the tumor may be useful in predicting long‐term tumor control and treatment outcome in cervical cancer. J. Magn. Reson. Imaging 2000;12:1027–1033.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2000
Brenton B. Koch; Lucy Hynds Karnell; Henry T. Hoffman; Louis W. Apostolakis; Robert A. Robinson; W. Zhen; Herman R. Menck
Management of chondrosarcoma of the head and neck is largely based on single‐institution reports with small numbers accrued over several decades.
Cancer | 2001
Brenton B. Koch; Douglas K. Trask; Henry T. Hoffman; Lucy Hynds Karnell; Robert A. Robinson; W. Zhen; Herman R. Menck
Verrucous carcinoma is distinguished by controversy regarding appropriate diagnosis and treatment. This study provides a contemporary survey of demographics, patterns of care, and outcome for this disease in the United States.
American Journal of Clinical Oncology | 2002
Arnold C. Paulino; B.-Chen Wen; John M. Buatti; David H. Hussey; W. Zhen; Nina A. Mayr; Arnold H. Menezes
From 1965 to 1997, 49 patients were diagnosed and treated for intracranial ependymoma at one institution. Tumor location was infratentorial in two thirds, and pathology was low grade in 38 patients (78%). Gross total resection of the primary tumor was achieved in 21 (43%). Thirty-six patients received adjuvant radiotherapy; the entire neuraxis was treated in 14, whole brain in 10, and local field only in 12. Median follow-up was 9.6 years (range, 2–33 years). The 5-, 10-, and 15-year overall survival rates were 71.4%, 63.5%, and 63.5% for craniospinal radiotherapy, 60.0%, 60.0%, and 40.0% for whole brain radiotherapy, and 80.8%, 64.6%, and 64.6% for local field radiotherapy (p = 0.88). The 5-, 10-, and 15-year local control rates were 60.3%, 54.4%, and 48.9%. The prognostic factors for a better local control rate were gross total resection (p = 0.021) and low grade histology (p = 0.031). Seventeen of 43 (39.5%) M0 patients did not respond to treatment; all had local failure and 4 also had a spinal relapse. Spinal relapse developed in 3 of 31 (10%) M0 patients who did not receive spinal radiotherapy, whereas 1 of 12 (8%) who had spinal radiotherapy did not respond to treatment in the spine. The results of this study indicate that local radiotherapy is sufficient for M0 patients with intracranial ependymoma.
Cancer | 2003
Russell B. Smith; Louis W. Apostolakis; Lucy Hynds Karnell; Brenton B. Koch; Robert A. Robinson; W. Zhen; Herman R. Menck; Henry T. Hoffman
Osteosarcoma is the most common primary bone malignancy overall but is encountered infrequently in the head and neck. Limited data are available on the significance of prognostics factors and results of therapy for patients with head and neck osteosarcoma (HNOS). It is known that surgical therapy is critical to successful outcome. The impact of adjuvant chemotherapy has not been defined well.
Laryngoscope | 2001
James H. Simon; W. Zhen; Timothy M. McCulloch; Henry T. Hoffman; Arnold C. Paulino; Nina A. Mayr; John M. Buatti
Objective Esthesioneuroblastoma is rare and the best treatment has yet to be defined. The purpose of this study is to analyze the natural history, treatment, and patterns of failure of esthesioneuroblastoma treated at one institution.
Laryngoscope | 2000
David J. Arnold; Gerry F. Funk; Lucy Hynds Karnell; Achih H. Chen; Henry T. Hoffman; Joan M. Ricks; M. Bridget Zimmerman; Dean Corbae; W. Zhen; Timothy M. McCulloch; Scott M. Graham
Objectives: To examine the relationship of various pretreatment case‐mix characteristics and treatment modalities with medical charges incurred during diagnosis, treatment, and 2‐year follow‐up for patients with laryngeal cancer.
International Journal of Radiation Oncology Biology Physics | 1998
Nina A. Mayr; Joel I. Sorosky; W. Zhen; Geoffrey J. Weidner; David H. Hussey; Barrie Anderson; Richard E. Buller
PURPOSE Osmotic dilators (laminarias) have been used for gradual nontraumatic dilation of the cervical canal for various intrauterine procedures; however, this technique has not been well accepted in gynecological brachytherapy. The purpose of this study was to evaluate the efficacy of osmotic cervical dilation for brachytherapy in gynecologic cancer patients, without the use of general/regional anesthesia, and to assess patient tolerance, complications, and outcome. METHODS AND MATERIALS Thirteen brachytherapy procedures were performed in 6 patients with clinical Stages I and II endometrial (5) and Stage IB cervical cancer (1), who were unable to tolerate general/regional anesthesia because of severe medical problems. An osmotic dilator (synthetic laminaria) was inserted into the cervical os 10-12 h before each brachytherapy procedure and removed just before the procedure. Standard Fletcher-Suit-Delclos tandem insertions with vaginal colpostats or cylinders were then performed. Degree of cervical dilation, patient discomfort, procedure time, intra- and postoperative complications were recorded, and local control and survival were assessed. Median follow-up was 31 months (range: 8-35 months). RESULTS The diameter of the dilated cervical os after laminaria removal was adequate (> or = 5 mm) for tandem insertion, and no additional mechanical dilation was required in all but one procedure (1 of 13). All procedures were performed without general/regional anesthesia. The mean duration of the procedures was 44 min (range, 20-60 min). Discomfort was minimal in all cases. There were no intra- or postoperative complications. All patients maintained local control until death (1 of metastatic disease, 2 of intercurrent disease) or last follow-up (2 with no evidence of disease, 1 alive with metastatic disease). CONCLUSION This preliminary study suggests that osmotic cervical dilation with a synthetic laminaria is a useful technique to facilitate intrauterine tandem insertion in patients who cannot tolerate general/regional anesthesia. This technique may reduce treatment-associated morbidity, shorten procedure time, and allow the delivery of adequate radiation therapy in this uncommon but challenging patient population.